Suboxone News

Indivior to Resolve U.S. Opioid Treatment Marketing Claims For $600 Million

Indivior Plc on Friday said it had agreed to pay $600 million and have a subsidiary plead guilty to a criminal charge to resolve U.S. allegations that it engaged in an illegal scheme to boost prescriptions of its opioid addiction …

Former Indivior CEO Pleads Guilty in U.S. in Opioid Addiction Treatment Probe

Shaun Thaxter, the former chief executive of drugmaker Indivior Plc, pleaded guilty on Tuesday to a criminal charge arising out of a U.S. Justice Department investigation into the marketing of its opioid addiction treatment Suboxone. Thaxter pleaded guilty in federal …

Drug Distributor Reckitt to Pay $700 Million Over Opioid Marketing

Drug distributor Reckitt Benckiser Group agreed to a $700 million settlement with six U.S. states over claims that the company improperly marketed and promoted the opioid-addiction treatment Suboxone. The marketing resulted in state Medicaid funds being improperly spent on the …

Teva Wins Patent Case Related to Orexo Opioid-Treatment Drug

A U.S. jury on Friday rejected a claim by Sweden’s Orexo AB that two generic opioid-addiction treatments created by Teva Pharmaceutical Industries Ltd. infringed a patent for Orexo’s biggest drug, Zubsolv. A Teva unit had created copies of the drugs …